Tarricone, R., Petracca, F. & Weller, H. M. Towards harmonizing assessment and reimbursement of digital medical devices in the EU through mutual learning. npj Digit. Med. 7, 268, (2024).
Google Scholar
Gordon, W. J. et al. Beyond validation: getting health apps into clinical practice. npj Digit. Med. 3, 14, (2020).
Google Scholar
European Union. Regulation (EU) 2021/2282 of the European Parliament and of the Council of 15 December 2021 on Health Technology Assessment and Amending Directive 2011/24/EU. Off. J. Eur. Union; (2021).
European Union. Proposal for a Regulation of the European Parliament and of the Council on the European Health Data Space (EHDS). COM(2022) 197 final, 2022/0140 (COD); (2022).
European Union. Regulation (EU) 2024/1689 of the European Parliament and of the Council of 13 June 2024 laying down harmonised rules on artificial intelligence (AI Act). Off. J. Eur. Union; (2024).
Coder, M., McBride, L. & McClenahan, S. Core elements of national policy for digital health technology evidence and access. npj Digit. Med. 7, 212, (2024).
Google Scholar
European Parliament & Council. Regulation (EU) 2017/745 of the European Parliament and of the Council on medical devices. Official Journal of the European Union (2017).
Gesetz Für Eine Bessere Versorgung Durch Digitalisierung Und Innovation (Digitale-Versorgung-Gesetz—DVG) [Digital Healthcare Act] BGBl I 2562 (2019).
Verordnung Über Das Verfahren Und Die Anforderungen Der Prüfung Der Erstattungsfähigkeit Digitaler Gesundheitsanwendungen in Der Gesetzlichen Krankenversicherung (Digitale Gesundheitsanwendungen-Verordnung—DiGAV) [Digital Health Applications-Ordinance] BGBl I 768 (2020).
Bundesministerium für Gesundheit. Gesetz Zur Beschleunigung Der Digitalisierung Des Gesundheitswesens (Digital-Gesetz); (2023).
Schmidt, L. et al. The three-year evolution of Germany’s Digital Therapeutics reimbursement program and its path forward. npj Digit. Med 7, 139, (2024).
Google Scholar
Ministère de la Santé et de la Prévention. Decree no. 2023-232 of March 30, 2023, relating to the early coverage of digital medical devices for therapeutic purposes and telemonitoring medical activities by health insurance. Off. J. French Repub. (2023).
mHealthBelgium. National platform for mobile health applications. mHealthBelgium; (2025).
International Organization for Standardization. ISO/TR 11147:2023(en), Health informatics — Personalized digital health — Digital therapeutics health software systems; (2023).
International Organization for Standardization. ISO 13131:2021Health informatics — Telehealth services — Quality planning guidelines; (2021).
Digital Therapeutics Alliance. Guidance to Industry: Classification of Digital Health Technologies; (2023).
UCL European Institute. Getting safe and effective digital medical devices to patients. UCL Insights Research Briefing. (2019).
European Commission, Directorate-General for Health and Food Safety. Flash report – member state coordination group on HTA (HTACG). (2023).
EIT Health. Digital medical devices: paths to European harmonisation. (2023).
Spreafico, A. et al. DTx Policy Pathways: The Evolving Scenario in Europe. Landscape Analysis & Converging Trends. DTx Policy Report: Healthware Group & Digital Therapeutics Alliance. (2023).
Chapman, S. Towards identifying good practices in the assessment of digital medical devices: Insights from several OECD countries. OECD Health Working Papers No. 177, OECD Publishing, Paris. (2025).
World Health Organization. Noncommunicable Diseases: Key Facts; (2024).
Bergram, K., Djokovic, M., Bezençon, V. & Holzer, A. The digital landscape of nudging: a systematic literature review of empirical research on digital nudges. Proc. 2022 CHI Conf. Hum. Factors Comput. Syst. 62, 1–16. (2022).
European Union. 2021/522 of the European Parliament and of the Council of 24 march 2021 establishing a Programme for the Union’s action in the field of health (‘EU4Health Programme’) for the period 2021-2027, and repealing Regulation (EU) No 282/2014. Off. J. Eur. Union; (2021).
European Commission. Healthier Together – EU Non-Communicable Diseases (NCDs) Initiative: Guidance Document. (2022).
U.S. Food and Drug Administration. Regulatory considerations for prescription drug-use-related software; (2023).
Tarricone, R. et al. An accelerated access pathway for innovative high-risk medical devices under the new European Union Medical Devices and health technology assessment regulations? Analysis and recommendations. Expert Rev. Med. Devices; (2023).
U.S. Food and Drug Administration. Medical device coverage initiatives: connecting payors – Payor Communication Task Force; (Accessed January 2025).
U.S. Food and Drug Administration, Medicines and Healthcare Products Regulatory Agency & Health Canada. Predetermined Change Control Plans for Machine Learning-Enabled Medical Devices: Guiding Principles. U.S. Food and Drug Administration (2023).
U.S. Food and Drug Administration. Marketing Submission Recommendations for a Predetermined Change Control Plan for Artificial Intelligence-Enabled Device Software Functions; (2024).
Tarricone, R., Petracca, F., Ciani, O. & Cucciniello, M. Distinguishing features in the assessment of mHealth apps. Expert Rev. Pharmacoeconomics Outcomes Res. 21, 1–9, (2021).
Google Scholar
NHS England. Digital Technology Assessment Criteria (DTAC). Transforming health and care through digital technology; (Accessed January 2025).
National Institute for Health and Care Excellence. Evidence standards framework for medical technologies (EVA); (Accessed January 2025).
Kristensen, F. B. et al. The HTA Core Model®—10 years of developing an international framework to share multidimensional value assessment. Value Health 20, 244–250, (2017).
Google Scholar
European Commission, Directorate-General for Health and Food Safety. Flash report – member state coordination group on HTA (HTACG) (16 November 2023). (2023).
Digital Medicine Society (DiMe). International Digital Health Regulatory Pathways; (Accessed January, 2025).
Brönneke, J. B., Herr, A., Reif, S. & Stern, A. D. Dynamic HTA for digital health solutions: opportunities and challenges for patient-centered evaluation. Int. J. Technol. Assess. Health Care 39, e72, (2023).
Google Scholar
Tarricone, R., Petracca, F., Cucciniello, M. & Ciani, O. Recommendations for developing a lifecycle, multidimensional assessment framework for mobile medical apps. Health Econ; (2022).
Stern, A. D. et al. Advancing digital health applications: priorities for innovation in real-world evidence generation. Lancet Digit. Health 4, e200–e206, (2022).
Google Scholar
Artificial Intelligence Evidence Standards Framework (AI-ESF) Team & NICE ESF Team. Developing Evidence Standards for Artificial Intelligence Technologies within the NICE Evidence Standards Framework for Digital Health Technologies. National Institute for Health and Care Excellence (NICE), London, UK. (2022).
The European Coordination Committee of the Radiological, Electromedical and Healthcare IT Industry (COCIR). Living repository: Market access pathways for digital health solutions; (2023).
Ministero della Salute. Decreto 9 giugno 2023: Adozione del programma nazionale di HTA. Gazzetta Ufficiale della Repubblica Italiana, Serie Generale, n.207; (2023).
Ministry of Labour, Health, and Solidarity. Decree of 16 May 2023. Setting the lump sum of the remote medical monitoring activity covered by the health insurance provided for in II and III of Article R. 162-95 of the Social Security Code, as well as the modulations applicable to these rates and the periodicity of their revision. Official Journal of the French Republic; (2023).
Ministry of Labour, Health, and Solidarity. Order of 22 April 2024. Fixing the values provided for in II of Article R. 162-117 of the Social Security Code for the financial compensation due for the anticipated coverage by health insurance of a digital medical device for therapeutic purposes. Official Journal of the French Republic; (2024).
National Institute for Health and Disability Insurance (INAMI). Convention for telemonitoring of therapeutic orientation for heart failure. (2025).
Mecklai, K., Smith, N., Stern, A. D. & Kramer, D. B. Remote Patient Monitoring – Overdue or Overused? N. Engl. J. Med. 384, 1384–1386, (2021).
Google Scholar
U.S. Department of Health and Human Services (HHS). Billing for remote patient monitoring; (2025).
Tarricone, R., Petracca, F., Svae, L., Cucciniello, M. & Ciani, O. Which behaviour change techniques work best for diabetes self-management mobile apps? Results from a systematic review and meta-analysis of randomised controlled trials. eBiomedicine; (2024).
Meyerowitz-Katz, G. et al. Rates of attrition and dropout in app-based interventions for chronic disease: systematic review and meta-analysis. J. Med. Internet Res. 22, e20283, (2020).
Google Scholar
Gensorowsky, D., Diekmannshemke, J., Witte, J., Rohn, I., Schneider, U. The Evolving German DiGA Market: Insights From a Claims Data Analysis; (2024).
European Parliament and Council. Decision (EU) 2022/2481 of 14 December 2022 establishing the Digital Decade Policy Programme 2030. Off. J. Eur. Union. L 323, 4–26; (2022).
Cucciniello, M., Petracca, F., Ciani, O. & Tarricone, R. Development features and study characteristics of mobile health apps in the management of chronic conditions: a systematic review of randomised trials. npj Digit. Med. 4, (2021).
Sapanel, Y. et al. Economic evaluation associated with clinical-grade mobile app-based digital therapeutic interventions: systematic review. J. Med. Internet Res. 25, e47094, (2023).
Google Scholar
link